The impact of maternal protein restriction during rat pregnancy upon renal expression of angiotensin receptors and vasopressin-related aquaporins.
BACKGROUND
Maternal protein restriction during rat pregnancy is known to impact upon fetal development, growth and risk of disease in later life. It is of interest to understand how protein undernutrition influences the normal maternal adaptation to pregnancy. Here we investigated the mechanisms regulating renal haemodynamics and plasma volume during pregnancy, in the context of both normal and reduced plasma volume expansion. The study focused on expression of renal angiotensin receptors (ATR) and vasopressin-related aquaporins (AQP), hypothesising that an alteration in the balance of these proteins would be associated with pregnancy per se and with compromised plasma volume expansion in rats fed a low-protein diet.


METHODS
Female Wistar rats were mated and fed a control (18% casein) or low-protein (9% casein) diet during pregnancy. Animals were anaesthetised on days 5, 10, 15 and 20 of gestation (n = 8/group/time-point) for determination of plasma volume using Evans Blue dye, prior to euthanasia and collection of tissues. Expression of the ATR subtypes and AQP2, 3 and 4 were assessed in maternal kidneys by PCR and western blotting. 24 non-pregnant Wistar rats underwent the same procedure at defined points of the oestrous cycle.


RESULTS
As expected, pregnancy was associated with an increase in blood volume and haemodilution impacted upon red blood cell counts and haemoglobin concentrations. Expression of angiotensin II receptors and aquaporins 2, 3 and 4 was stable across all stages of the oestrus cycle. Interesting patterns of intra-renal protein expression were observed in response to pregnancy, including a significant down-regulation of AQP2. In contrast to previous literature and despite an apparent delay in blood volume expansion in low-protein fed rats, blood volume did not differ significantly between groups of pregnant animals. However, a significant down-regulation of AT2R protein expression was observed in low-protein fed animals alongside a decrease in creatinine clearance.


CONCLUSIONS
Regulatory systems involved in the pregnancy-induced plasma volume expansion are susceptible to the effects of maternal protein restriction.
Cornock
Ruth
R
School of Biosciences, University of Nottingham, Sutton Bonington Campus, Loughborough LE12 5RD, UK.
Langley-Evans
Simon C
SC
Mobasheri
Ali
A
McMullen
Sarah
S
D000818:Animals; D020346:Aquaporins / Q000737:chemistry / Q000235:genetics* / Q000378:metabolism; D001810:Blood Volume / Q000187:drug effects / Q000502:physiology; D018753:Diet, Protein-Restricted / Q000009:adverse effects; D004044:Dietary Proteins / Q000494:pharmacology; D005260:Female; D047109:Fetal Development / Q000187:drug effects / Q000502:physiology; D006439:Hemodynamics / Q000187:drug effects / Q000235:genetics; D007668:Kidney / Q000187:drug effects / Q000378:metabolism*; D039382:Maternal Nutritional Physiological Phenomena / Q000235:genetics / Q000502:physiology; D011247:Pregnancy; D011270:Pregnancy, Animal / Q000378:metabolism / Q000502:physiology; D051381:Rats; D017208:Rats, Wistar; D011945:Receptors, Angiotensin / Q000378:metabolism*; D014667:Vasopressins / Q000737:chemistry / Q000235:genetics / Q000378:metabolism
D020346:Aquaporins; D004044:Dietary Proteins; D011945:Receptors, Angiotensin; D014667:Vasopressins
J Physiol. 2005 Feb 1;562(Pt 3):937-50
15539403
Anal Biochem. 1976 May 7;72:248-54
942051
J Nutr. 1979 Nov;109(11):1887-92
501438
Med Princ Pract. 2010;19(2):87-98
20134170
Am J Obstet Gynecol. 1993 Dec;169(6):1382-92
8267033
Am J Physiol Heart Circ Physiol. 2009 Mar;296(3):H745-55
19151255
Am J Obstet Gynecol. 1998 Aug;179(2):486-91
9731858
Hypertension. 2006 Feb;47(2):203-8
16380519
Am J Physiol Regul Integr Comp Physiol. 2005 Jan;288(1):R85-90
15374820
Am J Physiol Regul Integr Comp Physiol. 2009 Nov;297(5):R1615-21
19776249
Curr Opin Pharmacol. 2006 Apr;6(2):202-7
16483846
Am J Physiol Regul Integr Comp Physiol. 2007 Feb;292(2):R794-9
16990489
J Physiol. 1982 Sep;330:81-93
7175756
J Clin Invest. 1998 Mar 1;101(5):1076-83
9486978
J Clin Endocrinol Metab. 1996 Mar;81(3):998-1002
8772564
Am J Physiol. 1997 Feb;272(2 Pt 2):F183-91
9124394
Proc Nutr Soc. 2009 Aug;68(3):306-20
19490740
Kidney Int. 1998 Dec;54(6):2056-63
9853271
J Soc Gynecol Investig. 2004 Oct;11(7):438-48
15458740
Clin Chem. 1980 Apr;26(5):555-61
7020989
J Clin Invest. 1996 Jun 15;97(12):2807-14
8675692
Am J Med. 2006 Jul;119(7 Suppl 1):S47-53
16843085
PLoS One. 2009;4(3):e4845
19287481
Clin Haematol. 1985 Oct;14(3):601-12
4075604
Hypertens Pregnancy. 2008;27(1):49-63
18293204
Hum Reprod. 2005 Nov;20(11):3157-62
16006463
Physiol Rev. 2002 Jan;82(1):205-44
11773613
Proc Natl Acad Sci U S A. 1995 Feb 14;92(4):1013-7
7532304
Cell Physiol Biochem. 2001;11(4):203-8
11509828
Am J Physiol Regul Integr Comp Physiol. 2006 Feb;290(2):R425-34
16166212
Clin Sci (Lond). 1992 Apr;82(4):377-81
1315647
Endocrinology. 2006 Nov;147(11):5126-31
16873529
Am J Physiol. 1989 Oct;257(4 Pt 2):R866-71
2802003
Nature. 1993 Feb 11;361(6412):549-52
8429910
Am J Physiol. 1997 Nov;273(5):F777-82
9374841
J Clin Invest. 1973 Nov;52(11):2682-9
4355997
Exp Nephrol. 1995 May-Jun;3(3):193-201
7542539
J Reprod Fertil. 1996 Mar;106(2):307-12
8699415
Obstet Gynecol. 1995 Mar;85(3):361-7
7862373
J Mol Histol. 2005 Feb;36(1-2):1-14
15703994
Br J Pharmacol. 2003 Nov;140(5):987-95
14530222
J R Soc Med. 2001 Jun;94(6):265-9
11387413
Nutr Rev. 1996 Jun;54(6):163-9
8810822
Clin Sci (Lond). 2002 May;102(5):553-60
11980575
Br J Obstet Gynaecol. 1979 May;86(5):364-70
465384
Am J Physiol Regul Integr Comp Physiol. 2007 Jul;293(1):R492-503
17442782